Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis

David H. Miller

doi:10.1602/neurorx.1.2.284

Home SearchPaper Details

Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis

David H. Miller

Springer Nature (2004) • Volume 1, Issue 2, Pages 284-294

PDF Available

Quick Actions

Read Full Paper

Publication Info

DOI

10.1602/neurorx.1.2.284

Language

English

Topic

Multiple Sclerosis Research Studies

Keywords

Multiple sclerosis, Medicine, Surrogate endpoint, Atrophy, Clinical trial, Magnetic resonance imaging, Neurology, Disease, Pathology, Clinical endpoint, Abnormality, Radiology, Immunology, Psychiatry

Published

March 30, 2004

Citations

125 citations

FWCI

7.02

External Resources

DOI Link OpenAlex

Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis

Quick Actions

Publication Info

External Resources

Suggested Papers

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

EPA guidance on assessment of negative symptoms in schizophrenia

Suggested Papers

Suggested Papers

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

EPA guidance on assessment of negative symptoms in schizophrenia